Preprint · OA
via OpenAlex
The key role of growth hormone–insulin–IGF-1 signaling in aging and cancer
Vladimir N. Anisimov, Andrzej Bartke
Critical Reviews in Oncology/Hematology · 2013 · ▲ 223 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.critrevonc.2013.01.005
- Canonical
- link ↗
- Fetched
- 2026-09-06 MST
Cite this
APA
Anisimov, V.N., & Bartke, A. (2013). The key role of growth hormone–insulin–IGF-1 signaling in aging and cancer. <em>Critical Reviews in Oncology/Hematology</em>. https://doi.org/10.1016/j.critrevonc.2013.01.005
Vancouver
Anisimov VN, Bartke A. The key role of growth hormone–insulin–IGF-1 signaling in aging and cancer. Critical Reviews in Oncology/Hematology. 2013. doi:10.1016/j.critrevonc.2013.01.005.
BibTeX
@unpublished{vladimir2013Thekey,
title = {The key role of growth hormone–insulin–IGF-1 signaling in aging and cancer},
author = {Vladimir N. Anisimov and Andrzej Bartke},
journal = {Critical Reviews in Oncology/Hematology},
year = {2013},
doi = {10.1016/j.critrevonc.2013.01.005},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pathology 2006
Citation only
The role of telomeres and telomerase in the pathology of human cancer and aging
Seminars in Cancer Biology 2011
Preprint · OA
Role of telomeres and telomerase in cancer
Trends in Genetics 2013
Preprint · OA
Telomerase at the intersection of cancer and aging
Molecular Medicine Today 1995
Citation only
Aging and cancer: are telomeres and telomerase the connection?
Aging 2011
Open access · CC-BY
Molecular damage in cancer: an argument for mTOR-driven aging
Current Genomics 2007
Open access · OA